Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 600 results for "Shionogi"

Two naldemedine Phase III studies show consistent improvement of opioid-induced constipation
Medical News Today

Two Naldemedine Phase III Studies Show Consistent Improvement ...

OSAKA, Japan and FLORHAM PARK, N.J. , May 23, 2016 /PRNewswire/ -- Shionogi today announced positive results from two identically-designed 12 week phase III studies (COMPOSE I and II) demonstrating consistent efficacy and safety of naldemedine in ... International Business Times, 4 days ago
New and Generic Drug Approvals: Ponstel U.S. Food and Drug Administration, 2 weeks ago
[x]  

1 images for "Shionogi"

Nasdaq, 1 month ago
LifeHealthPro

Crestor Developer Sees Sales Doubling On Lower-Priced Drugs

Shionogi made decision to stay away from expensive category CEO says in interview that ``partnerships are the way to go'' Across the pharmaceutical industry, companies have rushed towards medicines with sky-high prices -- making bets in ...
 Bloomberg1 month ago

GLAXOSMITHKLINE : ViiV Extends Licence Agreement For Dolutegravir

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its HIV joint venture with Pfizer Inc and Shionogi Ltd, ViiV Healthcare, has extended the coverage of its existing licence agreement with the Medicines Patent Pool for dolutegravir to ...
 4 Traders1 month ago GlaxoSmithKline's ViiV Extends Licence Agreement For Dolutegravir  London Stock Exchange1 month ago
4 Traders

Pragma Pharmaceuticals, LLC Announces Acquisition of Keflex®

Pragma Pharmaceuticals is pleased to announce that it has finalized the acquisition of the Keflex product line from Shionogi Inc. Keflex (Photo: Business Wire) Pragma is working toward launching later this moth with Fera Pharmaceuticals ...
 TMC Net1 month ago PRAGMA PHARMACEUTICALS : LLC Announces Acquisition of Keflex®  4 Traders1 month ago Pragma Pharmaceuticals Acquires Keflex  Citybizlist1 month ago Pragma Pharmaceuticals LLC Announces Acquisition of Keflex  Asian Hospital & Healthcare Management1 month ago
[x]  

Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020

1 of 5 FEATURED COMPANIES Allergan Inc. Bionovo Foamix Pharmaceuticals Novo Nordisk A/S Pep-Tonic Medical Shionogi & Co. Ltd. MORE About Post-Menopausal Vaginal Atrophy Drugs Vaginal atrophy also known as atrophic vaginitis is defined ...
 Research and Markets1 month ago Global Opioid Induced Constipation (OIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022  Research and Markets3 days ago Global Idiopathic Pulmonary Fibrosis 2016-2020 - Unmet Medical Needs Drives the Market - Research and Markets  4 Traders4 days ago Industry Overview on Global Flomoxef Sodium Consumption 2016  MyNewsDesk1 week ago
[x]  

F-6EF - SHIONOGI & CO LTD (0001281721) (Subject)

Form F-6EF - Registration of American Depository Receipt shares, immediately effective SEC Accession No. 0001193805-16-003117 Filing Date 2016-04-25 2016-04-25 16:30:12 Filing Date Changed 2016-04-25 Effectiveness Date 2016-04-25 ...
 SEC Filings1 month ago

UPDATED: FDA nitpicks Shionogi's head lice copay voucher over 'false and misleading' claims

The front of Shionogi's Ulesfia copay voucher.--Courtesy of the FDA Things are getting hairy for New Jersey-based pharma Shionogi and its head lice treatment Ulesfia. The FDA is chastising the company for putting out a copay coupon that talks ...
 FiercePharmaMarketing1 month ago FDA chastises Shionogi for misleading copay voucher  BioPharma Dive1 month ago

SHIONOGI : Study Results from Shionogi & Co. Ltd. Broaden Understanding of Pain Management (Effect of spinal monoaminergic neuronal system dysfunction on...

 4 Traders1 month ago
Monthly Prescribing Reference

Naldemedine NDA Submitted for Opioid-Induced Constipation

Share this article: A Phase 3 trial previously demonstrated the efficacy of Naldemedine Shionogi announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for naldemedine 0.2mg once daily tablet for ...
 Monthly Prescribing Reference1 month ago

New Arrivo: Triangle pharma wizards put $49M to work

Posted May. 27, 2016 at 6:23 a.m. Published: 2016-05-27 06:23:23 Updated: 2016-05-27 06:23:23 Arrivo Related Blog Posts Site Search By JIM SHAMP, NCBiotech Writer Research Triangle Park, N.C. — Here they go again. A group ...
 Local Tech Wire20 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less